课题基金 / 基金详情

PHASE III TRIAL OF INTRAVENOUS RHM-CSF IN PATIENTS WITH SOFT TISSUE SARCOMA

PHASE III TRIAL OF INTRAVENOUS RHM-CSF IN PATIENTS WITH SOFT TISSUE SARCOMA
软组织肉瘤患者静脉注射 RHM-CSF 的 III 期试验
批准号：
3785790
负责人：
RONALD BLUM
金额：
$0.0万
依托单位：
NEW YORK UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3785790
关键词：
clinical trials colony stimulating factor drug screening /evaluation human subject human therapy evaluation intravenous administration neoplasm /cancer immunotherapy recombinant proteins sarcoma

项目摘要

项目成果

RONALD BLUM的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The primary objective of this multicenter study is to estimate the efficacy of recombinant human macrophage colony stimulating factor (rhM-CSF) administered by continuous intravenous infusion at 80 ug/kg/day in adult patients with soft tissue sarcoma, as measured by changes in tumor measurements.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ECOG C9344 DOXORUBICIN DOSE ESCALATION +/- TAXOL FOR NODE POSITIVE BREAST CANCER
SWOG 94-20 CORRELATION OF THYMIDYLATE SYNTHASE IN 5 FU TREATED COLORECTAL CANCER
ECOG S9313--ADJUVANT CHEMOTHERAPY IN HIGH RISK BREAST CANCER PATIENTS
ECOG 91140--CDP, DTIC, CARMUSTINE & TAMOXIFEN VS DTIC IN ADVANCED MELANOMA
海外基金